49
Participants
Start Date
September 7, 2012
Primary Completion Date
July 1, 2018
Study Completion Date
January 16, 2019
Cabozantinib
Assigned dose given daily during each 21 day cycle. Treatment may continue until disease progression or intolerable toxicity.
Docetaxel
75mg/m\^2 intravenous (IV) over approximately 60 minutes on cycle 1 day 1 and repeated every 21 days until disease progression or intolerable toxicity.
Prednisone
5 mg by mouth (PO) twice a day during each 21 day cycle until disease progression or intolerable toxicity.
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
National Cancer Institute (NCI)
NIH